Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives
Chunqing Lin, Sarah E. Clingan, Sarah J. Cousins, et al.
Journal of Substance Abuse Treatment (2021) Vol. 133, pp. 108544-108544
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The first five years of implementing Missouri's medication first approach to opioid use disorder treatment: Plateaus, regressions, and underbellies of progress
Rachel P. Winograd, Brandon Park, Bridget Coffey, et al.
Journal of Substance Use and Addiction Treatment (2025) Vol. 170, pp. 209622-209622
Open Access | Times Cited: 1
Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments
Hossam Mahmoud, Hady Naal, Emile Whaibeh, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 9, pp. 375-386
Open Access | Times Cited: 38
Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
Fiona N. Conway, Jake Samora, Katlyn Brinkley, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 37
Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States
Chunqing Lin, Huyen Pham, Yuhui Zhu, et al.
Drug and Alcohol Dependence (2022) Vol. 242, pp. 109711-109711
Open Access | Times Cited: 27
Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID
Beth E. Meyerson, Keith Gunnar Bentele, Danielle M. Russell, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0274094-e0274094
Open Access | Times Cited: 22
Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis
Julia Dickson‐Gõmez, Margaret R. Weeks, Danielle Green, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 3, pp. 100051-100051
Open Access | Times Cited: 20
The provision and utilization of essential health services in Afghanistan during COVID-19 pandemic
Narges Neyazi, Christina Lindan, Saber Perdes, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 8
A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic
Alisa B. Busch, Ateev Mehrotra, Shelly F. Greenfield, et al.
Journal of Substance Abuse Treatment (2022) Vol. 144, pp. 108920-108920
Open Access | Times Cited: 12
Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey
Sarah Brothers, Adam Palayew, Caty Simon, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
“Sign Me Up”: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic
James Darnton, Elenore P. Bhatraju, Kristin Beima‐Sofie, et al.
Addiction Science & Clinical Practice (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
“It's my frenemy”: A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA
Sarah Bauerle Bass, Patrick J. Kelly, Sphoorti Pandit-Kerr, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 9
Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study
Katy Holloway, Shannon Murray, Marian Buhociu, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 9
What can we learn from COVID-19 to improve opioid treatment? Expert providers respond
Lesley M. Harris, Jeanne C. Marsh, Tenie Khachikian, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 154, pp. 209157-209157
Open Access | Times Cited: 3
Racial/Ethnic disparities in drug use during the COVID 19 pandemic: Moderating effects of non-profit substance use disorder service expenditures
Hyunjung Ji, Su Hyun Shin, Annah Rogers, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0270238-e0270238
Open Access | Times Cited: 5
Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder
Katherine Shircliff, Melissa Liu, Christiana J. Prestigiacomo, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0270582-e0270582
Open Access | Times Cited: 5
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic
Sarah Meshberg‐Cohen, Minnah W. Farook, Georgina M. Gross, et al.
American Journal on Addictions (2022) Vol. 32, Iss. 1, pp. 32-39
Closed Access | Times Cited: 5
Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder
Sarah E. Clingan, Sarah J. Cousins, Chunqing Lin, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 480-489
Open Access | Times Cited: 2
Ethical Dilemmas Facing Substance Use Counselors During the COVID-19 Pandemic
Caravella McCuistian, J. Konadu Fokuo, Jaime Dumoit Smith, et al.
Substance Abuse Research and Treatment (2023) Vol. 17, pp. 117822182311583-117822182311583
Open Access | Times Cited: 2
Professionals’ Views on Challenges in Inpatient Substance Abuse Treatment during COVID-19 Pandemic in Finland
Eeva Ekqvist, Tuija Karsimus, Arja Ruisniemi, et al.
Challenges (2022) Vol. 13, Iss. 1, pp. 6-6
Open Access | Times Cited: 3
Understanding the Effect of the COVID-19 Pandemic on Substance Use Disorder Treatment Facility Operations and Patient Success: Evidence From Mississippi
Devon Meadowcroft, Will Davis
Substance Abuse Research and Treatment (2022) Vol. 16
Open Access | Times Cited: 3
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents
Grace Noonan, Jason Glenn
Journal of Addiction Medicine (2023) Vol. 17, Iss. 4, pp. e211-e216
Open Access | Times Cited: 1
Implementing an EMA burst design in community-engaged research: participant and researcher perspectives and recommendations
Ashley C. Helle, Lindsey K. Freeman, Amelia M. Pellegrini, et al.
The American Journal of Drug and Alcohol Abuse (2023) Vol. 49, Iss. 1, pp. 53-62
Open Access | Times Cited: 1
Referral of patients from rural primary care clinics to telemedicine vendors for opioid use disorder treatment: A mixed-methods study
Chunqing Lin, Yuhui Zhu, Larissa J. Mooney, et al.
Journal of Telemedicine and Telecare (2024)
Closed Access
Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population
Cecilia L. Bergeria, Brandon Park, Prem Umang Satyavolu, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Heterogeneous Trajectories in Post-Disaster Drug Use Across Different Race/Ethnicity and Income Strata: Focus on Natural Hazards During COVID-19
Hyunjung Ji, Su Hyun Shin, HanNa Lim
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access
Page 1 - Next Page

Scroll to top